102
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Relationship Between Preoperative and Postoperative Serum Carcinoembryonic Antigen and Prognosis of Patients with Stage I–III Rectal Cancer: A Retrospective Study of a Multicentre Cohort of 1022 Rectal Cancer Patients

ORCID Icon, , , , , , & ORCID Icon show all
Pages 2643-2651 | Published online: 18 Mar 2021

References

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
  • Boland PM, Ma WW. Immunotherapy for Colorectal Cancer. Cancers (Basel). 2017;9:5. doi:10.3390/cancers9050050
  • Network NCC. NCCN Clinical Practice. Guidelines in Oncology (NCCN Guidelines): Colon Cancer. (Version 2.2018). Fort Washington, PA: National Comprehensive Cancer Network; 2018.
  • Network NCC. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Rectal Cancer. (Version 3.2018). Fort Washington, PA: National Comprehensive Cancer Network; 2018.
  • Konishi T, Shimada Y, Hsu M, et al. Association of preoperative and postoperative serum carcinoembryonic antigen and colon cancer outcome. JAMA Oncol. 2018;4(3):309–315. doi:10.1001/jamaoncol.2017.442029270608
  • Gold P, Freedman SO. Demonstration of tumor specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med. 1965;121:439–462.14270243
  • Meyerhardt JA, Mangu PB, Flynn PJ, et al. American Society of Clinical Oncology. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: american Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2013;31(35):4465–4470. doi:10.1200/JCO.2013.50.744224220554
  • Sener SF, Imperato JP, Chmiel J, et al. The use of cancer registry data to study preoperative carcinoembryonic antigen level as an indicator of survival in colorectal cancer. CA Cancer J Clin. 1989;39(1):50–57.2492877
  • Herrera MA, Chu TM, Holyoke ED, et al. Carcinoembryonic antigen (CEA) as a prognostic and monitoring test in clinically complete resection of colorectal carcinoma. Ann Surg. 1976;183(1):5–9.1247300
  • Goslin R, Steele G, Macintyre J, et al. The use of preoperative plasma CEA levels for the Stratification of patients after curative resection of colorectal cancers. Ann Surg. 1980;192(6):747–751.7447529
  • Auclin E, André T, Taieb J, et al. Low-level postoperative carcinoembryonic antigen improves survival outcomes stratification in patients with stage II colon cancer treated with standard adjuvant treatments. Eur J Cancer. 2018;97:55–56.29731226
  • Vallam KC, Guruchannabasavaiah B, Agrawal A, et al. Carcinoembryonic antigen directed PET-CECT scanning for postoperative surveillance of colorectal cancer. Colorectal Dis. 2017;19(10):907–911.28444968
  • Wang JY, Lu CY, Chu KS, et al. Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer. Eur Surg Res. 2007;39(4):245–250.17457032
  • Laurence DJ, Turberville C, Anderson SG, Neville AM. First British standard for carcinoembryonic antigen (CEA). Br J Cancer. 1975;32:295–299.822862
  • Li Z, Li S, Liang Y, et al. Predictive value of postoperative peripheral CD4+ T cells percentage in Stage I-III colorectal cancer: a retrospective multicenter cohort study of 1028 subjects. Cancer Manag Res. 2020;12:5505–5513.32753965
  • Von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457. doi:10.1016/s0140-6736(07)61602-x18064739
  • Kim JY, Kim NK, Sohn SK, et al. Prognostic value of postoperative CEA clearance in rectal cancer patients with high preoperative CEA levels. Ann Surg Oncol. 2009;16(10):2771–2778.19657698
  • Ma CJ, Hsieh JS, Wang WM, et al. Multivariate analysis of prognostic determinants for colorectal cancer patients with high preoperative serum CEA levels: prognostic value of postoperative serum CEA levels. Kaohsiung J Med Sci. 2006;22(12):604–609.17116621
  • Ramphal W, Boeding JRE, van Iwaarden M, et al. Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer. Int J Biol Markers. 2019;34(1):60–68.30852955
  • Khan MS, Khan MA, Akbar SA, et al. Prognostic significance of pre- and post-operative serum carcinoembryonic antigen levels in patients presented with rectal carcinoma; an experience from Shaukat Khanum Memorial Cancer Hospital and Research Center Lahore. J Pak Med Assoc. 2019;69(10):1431–1436.
  • Snyder RA, Hu CY, Cuddy A. Alliance for clinical trials in oncology network cancer surveillance optimization working group, et al.association between intensity of posttreatment surveillance testing and detection of recurrence in patients with colorectal cancer. JAMA. 2018;319(20):2104–2115.29800181
  • Kim SS, Donahue TR, Girgis MD, et al. Carcinoembryonic antigen for diagnosis of colorectal cancer recurrence. JAMA. 2018;320(3):298–299.30027230
  • Saito G, Sadahiro S, Kamata H, et al. Monitoring of serum carcinoembryonic antigen levels after curative resection of colon cancer: cutoff values determined according to preoperative levels enhance the diagnostic accuracy for recurrence. Oncology. 2017;92(5):276–282.28178692
  • Huh JW, Kim CH, Lim SW, et al. Factors predicting long-term survival in colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen. J Cancer Res Clin Oncol. 2013;139(9):1449–1455.23765330
  • Yakabe T, Nakafusa Y, Sumi K, et al. Clinical significance of CEA and CA19-9 in postoperative follow-up of colorectal cancer. Ann Surg Oncol. 2010;17(9):2349–2356.20217258
  • Barton MK, et al. False elevations of carcinoembryonic antigen levels are common in patients under surveillance for colorectal cancer recurrence.CA. Cancer J Clin. 2014;64(6):365–366.